Wireless computing in medicine : from nano to cloud with ethical and legal aspects / edited by Mary Mehrnoosh EshaghianWilner.

Format:

Book

Contributor:

Eshaghian-Wilner, Mary Mehrnoosh, editor.

Series:

Nature-inspired computing series.

THEi Wiley ebooks.

Nature-Inspired Computing Series

THEi Wiley ebooks

Language:

English

Subjects (All):

Telecommunication in medicine--Moral and ethical aspects.

Telecommunication in medicine.

Telecommunication in medicine--Law and legislation.

Nanotechnology.

Physical Description:

1 online resource (758 pages) : illustrations (some color), photographs.

Edition:

1st ed.

Place of Publication:

Hoboken, New Jersey : Wiley, 2016.

System Details:

Access using campus network via VPN at home (THEi Users Only).

Summary:

"Provides a comprehensive overview of wireless computing in medicine, with technological, medical, and legal advances This book brings together the latest work of leading scientists in the disciplines of Computing, Medicine, and Law, in the field of Wireless Health. The book is organized into three main sections. The first section discusses the use of distributed computing in medicine. It concentrates on methods for treating chronic diseases and cognitive disabilities like Alzheimer, Autism, etc. It also discusses how to improve portability and accuracy of monitoring instruments and reduce the redundancy of data. It emphasizes the privacy and security of using such devices. The role of mobile sensing, wireless power and Markov decision process in distributed computing is also examined. The second section covers nanomedicine and discusses how the drug delivery strategies for chronic diseases can be efficiently improved by Nanotechnology enabled materials and devices such as MENs and Nanorobots. The authors will also explain how to use DNA computation in medicine, model brain disorders and detect bio-markers using nanotechnology. The third section will focus on the legal and privacy issues, and how to implement these technologies in a way that is a safe and ethical. Defines the technologies of distributed wireless health, from software that runs cloud computing data centers, to the technologies that allow new sensors to work Explains the applications of nanotechnologies to prevent, diagnose and cure disease Includes case studies on how the technologies covered in the book are being implemented in the medical field, through both the creation of new medical applications and their integration into current systems Discusses pervasive computing's organizational benefits to hospitals and health care organizations, and their ethical and legal challenges Wireless Computing in Medicine: From Nano to Cloud with Its Ethical and Legal Implications is written as a reference for computer engineers working in wireless computing, as well as medical and legal professionals. The book will also serve students in the fields of advanced computing, nanomedicine, health informatics, and technology law"-- Provided by publisher.

"Discusses pervasive computing's organizational benefits to hospitals and health care organizations, and their ethical and legal challenges"-- Provided by publisher.

Contents:

Intro

TITLE PAGE

TABLE OF CONTENTS

CONTRIBUTORS

FOREWORD

PREFACE

PART I: INTRODUCTION

1 INTRODUCTION TO WIRELESS COMPUTING IN MEDICINE

1.1 INTRODUCTION

1.2 DEFINITION OF TERMS

1.3 BRIEF HISTORY OF WIRELESS HEALTHCARE

1.4 WHAT IS WIRELESS COMPUTING?

1.5 DISTRIBUTED COMPUTING

1.6 NANOTECHNOLOGY IN MEDICINE

1.7 ETHICS OF MEDICAL WIRELESS COMPUTING

1.8 PRIVACY IN WIRELESS COMPUTING

1.9 CONCLUSION

REFERENCES

2 NANOCOMPUTING AND CLOUD COMPUTING

2.1 INTRODUCTION

2.2 NANOCOMPUTING

2.3 CLOUD COMPUTING

2.4 CONCLUSION

ACKNOWLEDGMENT

PART II: PERVASIVE WIRELESS COMPUTING IN MEDICINE

3 PERVASIVE COMPUTING IN HOSPITALS

3.1 INTRODUCTION

3.2 ARCHITECTURE OF PERVASIVE COMPUTING IN HOSPITALS

3.3 SENSORS, DEVICES, INSTRUMENTS, AND EMBEDDED SYSTEMS

3.4 DATA ACQUISITION IN PERVASIVE COMPUTING

3.5 SOFTWARE SUPPORT FOR CONTEXT‐AWARE AND ACTIVITY SHARING SERVICES

3.6 DATA AND INFORMATION SECURITY

3.7 CONCLUSION

4 DIAGNOSTIC IMPROVEMENTS

4.1 INTRODUCTION

4.2 SYSTEM DESIGN

4.3 BODY SENSOR NETWORK

4.4 PORTABLE SENSORS

4.5 WEARABLE SENSORS

4.6 IMPLANTABLE SENSORS

4.7 WIRELESS COMMUNICATION

4.8 MOBILE BASE UNIT

4.9 CONCLUSION AND CHALLENGES

5 COLLABORATIVE OPPORTUNISTIC SENSING OF HUMAN BEHAVIOR WITH MOBILE PHONES

5.1 HEALTH AND MOBILE SENSING

5.2 THE InCense SENSING TOOLKIT

5.3 SENSING CAMPAIGN 1: DETECTING BEHAVIORS ASSOCIATED WITH THE FRAILTY SYNDROME AMONG OLDER ADULTS

5.4 SENSING CAMPAIGN 2: DETECTING PROBLEMATIC BEHAVIORS AMONG ELDERS WITH DEMENTIA

5.5 DISCUSSION

5.6 CONCLUSIONS AND FUTURE WORK

6 PERVASIVE COMPUTING TO SUPPORT INDIVIDUALS WITH COGNITIVE DISABILITIES

6.1 INTRODUCTION.

6.2 WEARABLE AND MOBILE SENSING PLATFORMS TO EASE THE RECORDING OF DATA RELEVANT TO CLINICAL CASE ASSESSMENT

6.3 AUGMENTED REALITY AND MOBILE AND TANGIBLE COMPUTING TO SUPPORT COGNITION

6.4 SERIOUS GAMES AND EXERGAMES TO SUPPORT MOTOR IMPAIRMENTS

6.5 CONCLUSIONS

ACKNOWLEDGMENTS

7 WIRELESS POWER FOR IMPLANTABLE DEVICES

7.1 INTRODUCTION

7.2 HISTORY OF WIRELESS POWER

7.3 APPROACH OF WIRELESS POWER TRANSMISSION

7.4 A DETAILED EXAMPLE OF MAGNETIC COUPLING RESONANCE

7.5 POPULAR STANDARDS

7.6 WIRELESS POWER TRANSMISSION IN MEDICAL USE

7.7 CONCLUSION

8 ENERGY‐EFFICIENT PHYSICAL ACTIVITY DETECTION IN WIRELESS BODY AREA NETWORKS

8.1 INTRODUCTION

8.2 KNOWME PLATFORM

8.3 ENERGY IMPACT OF DESIGN CHOICES

8.4 PROBLEM FORMULATION

8.5 SENSOR SELECTION STRATEGIES

8.6 ALTERNATIVE PROBLEM FORMULATION

8.7 SENSOR SELECTION STRATEGIES FOR THE ALTERNATIVE FORMULATION

8.8 EXPERIMENTS

8.9 RELATED WORK

8.10 CONCLUSION

9 MARKOV DECISION PROCESS FOR ADAPTIVE CONTROL OF DISTRIBUTED BODY SENSOR NETWORKS

9.1 INTRODUCTION

9.2 RATIONALE FOR MDP FORMULATION

9.3 RELATED WORK

9.4 PROBLEM STATEMENT, ASSUMPTIONS, AND APPROACH

9.5 MDP MODEL FOR MULTIPLE SENSOR NODES

9.6 COMMUNICATION

9.7 SIMULATION RESULTS

9.8 CONCLUSIONS

PART III: NANOSCALE WIRELESS COMPUTING IN MEDICINE

10 AN INTRODUCTION TO NANOMEDICINE

10.1 INTRODUCTION

10.2 NANOMEDICAL TECHNOLOGY

10.3 DETECTION

10.4 TREATMENT

10.5 BIOCOMPATIBILITY

10.6 POWER

10.7 COMPUTER MODELING

10.8 RESEARCH INSTITUTIONS

10.9 CONCLUSION

11 NANOMEDICINE USING MAGNETO‐ELECTRIC NANOPARTICLES

11.1 INTRODUCTION

11.2 OVERVIEW OF MENs.

11.3 EXPERIMENT 1: EXTERNALLY CONTROLLED ON‐DEMAND RELEASE OF ANTI‐HIV DRUG AZTTP USING MENS AS CARRIERS

11.4 EXPERIMENT 2: MENS TO ENABLE FIELD‐CONTROLLED HIGH‐SPECIFICITY DRUG DELIVERY TO ERADICATE OVARIAN CANCER CELLS

11.5 EXPERIMENT 3: MAGNETOELECTRIC "SPIN" ON STIMULATING THE BRAIN

11.6 BIOCERAMICS: BONE REGENERATION AND MNS

11.7 CONCLUSION

12 DNA COMPUTATION IN MEDICINE

12.1 BACKGROUND FOR THE NON‐BIOLOGIST

12.2 INTRODUCTION

12.3 IN VITRO COMPUTING

12.4 COMPUTATION IN VIVO

12.5 CHALLENGES

12.6 GLIMPSE INTO THE FUTURE

13 GRAPHENE‐BASED NANOSYSTEMS FOR the DETECTION OF PROTEINIC BIOMARKERS OF DISEASE

13.1 INTRODUCTION

13.2 STRUCTURAL AND PHYSICOCHEMICAL PROPERTIES OF GRAPHENE AND MAIN DERIVATIVES

13.3 GRAPHENE AND DERIVATIVES‐BASED BIOSENSING NANOSYSTEMS AND APPLICATIONS

13.4 CONCLUSION AND PERSPECTIVES

CONFLICT OF INTEREST

14 MODELING BRAIN DISORDERS IN SILICON NANOTECHNOLOGIES

14.1 INTRODUCTION

14.2 THE BioRC PROJECT

14.3 BACKGROUND: BioRC NEURAL CIRCUITS

14.4 MODELING SYNAPSES WITH CNT TRANSISTORS

14.5 MODELING OCD WITH HYBRID CMOS/NANO CIRCUITS

14.6 THE BIOLOGICAL CORTICAL NEURON AND HYBRID ELECTRONIC CORTICAL NEURON

14.7 BIOLOGICAL OCD CIRCUIT AND BIOMIMETIC MODEL

14.8 INDIRECT PATHWAY: THE BRAKING MECHANISM

14.9 DIRECT PATHWAY: THE ACCELERATOR

14.10 TYPICAL AND ATYPICAL RESPONSES

14.11 MODELING SCHIZOPHRENIC HALLUCINATIONS WITH HYBRID CMOS/NANO CIRCUITS

14.12 EXPLANATION FOR SCHIZOPHRENIA SYMPTOMS

14.13 DISINHIBITION DUE TO MISWIRING

14.14 OUR HYBRID NEUROMORPHIC PREDICTION NETWORK

14.15 SIMULATION RESULTS

14.16 NUMERICAL ANALYSIS OF FALSE FIRING

14.17 MODELING PD WITH CMOS CIRCUITS

14.18 MODELING MS WITH CMOS CIRCUITS

14.19 DEMYELINATION CIRCUIT

14.20 CONCLUSIONS AND FUTURE TRENDS.

REFERENCES

15 LINKING MEDICAL NANOROBOTS TO PERVASIVE COMPUTING

15.1 INTRODUCTION

15.2 COMPLEMENTARY FUNCTIONALITIES

15.3 MAIN SPECIFICATIONS FOR SUCH NANOROBOTIC AGENTS (NANOROBOTS)

15.4 MEDICAL NANOROBOTIC AGENTS-AN EXAMPLE

15.5 NANOROBOTIC COMMUNICATION LINKS ALLOWING PERVASIVE COMPUTING

15.6 TYPES OF INFORMATION

15.7 MEDICAL NANOROBOTIC AGENTS FOR MONITORING AND EARLY DETECTION

15.8 MEDICAL NANOROBOTICS AND PERVASIVE COMPUTING-MAIN CONDITIONS THAT MUST BE MET FOR ITS FEASIBILITY

15.9 CONCLUSION

16 NANOMEDICINE'S TRANSVERSALITY

16.1 INTRODUCTION

16.2 NANOMEDICINE'S PROMISES

16.3 ANALYSING IMPLICATIONS OF THE NANOMEDICINE PARADIGM

16.4 THE MOLECULAR UNDERPINNINGS OF NANOMEDICINE'S TRANSVERSALITY

16.5 NANOMEDICINE AS PREDICTIVE MEDICINE

16.6 NANOMEDICINE AS PERSONALIZED MEDICINE

16.7 NANOMEDICINE AS REGENERATIVE MEDICINE

16.8 CONCLUSION

PART IV: ETHICAL AND LEGAL ASPECTS OF WIRELESS COMPUTING IN MEDICINE

17 ETHICAL CHALLENGES OF UBIQUITOUS HEALTH CARE*

17.1 INTRODUCTION

17.2 A PHILOSOPHICAL FRAMEWORK

17.3 INFORMATION DEVIANCE

17.4 THE CURRENT FRENZY

17.5 GENETIC INFORMATICS

17.6 UBIQUITOUS INFORMATION TECHNOLOGY

17.7 STASIS VERSUS PROGRESS

17.8 PROBLEMATIC ETHICS

17.9 LEADERSHIP IN SCIENCE AND ENGINEERING ETHICS

17.10 CONCLUSION

18 THE ETHICS OF UBIQUITOUS COMPUTING IN HEALTH CARE

18.1 INTRODUCTION

18.2 UBIQUITOUS COMPUTING AND THE TRANSFORMATION OF HEALTH CARE: THREE VISIONS

18.3 CASE STUDY: CARDIAC IMPLANTED ELECTRICAL DEVICES

18.4 ETHICAL REFLECTIONS

18.5 CONCLUSIONS: THE NEED FOR SOCIO‐TECHNICAL DESIGN

19 PRIVACY PROTECTION OF ELECTRONIC HEALTHCARE RECORDS IN e‐HEALTHCARE SYSTEMS

19.1 INTRODUCTION

19.2 SECURITY AND PRIVACY CONCERNS OF EHR IN e‐HEALTHCARE SYSTEMS.

19.3 PRIVACY LAWS AND REGULATIONS OF EHRs

19.4 PRIVACY OF EHRs IN e‐HEALTHCARE SYSTEMS

19.5 DISCUSSION AND CONCLUSION

19.6 CONTRIBUTIONS AND FUTURE RESEARCH

20 ETHICAL, PRIVACY, AND INTELLECTUAL PROPERTY ISSUES IN NANOMEDICINE

20.1 INTRODUCTION

20.2 ETHICAL ISSUES

20.3 PRIVACY ISSUES

20.4 IP ISSUES

20.5 CONCLUSION

PART V: CONCLUSION

21 CONCLUDING REMARKS

21.1 WIRELESS COMPUTING IN HEALTH CARE

21.2 NANOMEDICINE

21.3 ETHICAL, PRIVACY, AND INTELLECTUAL PROPERTY ISSUES OF NANOMEDICINE AND WIRELESS COMPUTING

21.4 CONCLUSIONS

INDEX

END USER LICENSE AGREEMENT.

Notes:

Includes bibliographical references at the end of each chapters and index.

Description based on print version record.

ISBN:

9781118993613

1118993616

9781118993606

1118993608

9781118993620

1118993624

OCLC:

951678273